Overview:
Suboxone is used for reducing the dependency of drug addicts on drugs like heroine or morphine. Suboxone consist of two ingredients that is buprenorphine and naloxone. Buprenorphine is also known as a narcotic and it is an opioid medicine, whereas Naloxone helps in counteracting to the effects of opioid drugs. Suboxone can be prescribed to adults and children seeking social, psychological and medical care. Both these drugs work collectively in preventing withdrawal symptoms related to an opioid addiction.
Request Sample Report (Including Full TOC, Table & Figures) :
https://www.coherentmarketinsights.com/insight/request-sample/5000
Impact of COVID-19:
The COVID-19 pandemic has impacted the entire supply chain of the healthcare industry, mainly due to strict lockdown in several regions. The pandemic has impacted many sectors across the globe due to strict lockdowns imposed in several regions. Covid-19 has led to disturbances in distribution and supply chains in many regions. For instance, United Nations Office on Drugs and Crime published an article in June 2021, stating that distribution of naloxone, has been negatively impacted in about 57% nations globally. Regulatory authorities have tried to make the access to some drugs like methadone, buprenorphine or naloxone by reducing barriers.
Manufacturers in are facing challenges in transporting raw materials and labor shortage, hence affecting the production of suboxone, as many vehicles used in transportation were stuck at the state or country borders. During, COVID-19 there had been a high demand for suboxone, the unavailability of the drug has hindered the growth of the global suboxone market.
Furthermore, rise in the number of product launches is anticipated to propel the growth of the global suboxone market during the forecast period. For instance, Mylan N.V., launched generic suboxone sublingual film, manufactured by the, Indivior PLC in February 2019. This drug was used for treating opioid dependency.
Drivers:
Adoption of inorganic strategies like agreements by key players in the market is anticipated to propel the growth of the global suboxone market during the forecast period. For instance, Indivior PLC, declared their partnership with Alvogen, in February 2019 for selling or importing the generic buprenorphine and naloxone sublingual film product by Indivior PLC in the United States of America.
Moreover, rise in regulatory approvals for suboxone drugs is estimated to propel the growth of the global suboxone market, exhibiting a CAGR of 4.0% during the forecast period. For instance, Dr. Reddy’s Laboratories received an approval from U.S. FDA, in June 2018, for launching Naloxone and Buprenorphine Sublingual Film in the U.S. market.
Request PDF Brochure with Latest Insights :
https://www.coherentmarketinsights.com/insight/request-pdf/5000
Key Takeaways:
Increased product approvals is expected to boost the growth of the generics segment, amongst type segments in the global suboxone market during the forecast period. For instance, the U.S. FDA granted approval to the suboxone sublingual film, which is used in treating opioid dependence.
Furthermore, rise in the launches of buprenorphine and naloxone sublingual films is expected to fuel the growth of the global suboxne market during the forecast period. . For instance, Dr. Reddy’s Laboratories Ltd., declared the relaunch of buprenorphine and naloxone sublingual film in the U.S. market, in February 2019.
Key Players:
Key players in the Global Suboxone Market are Alkem Labs, Novartis AG, Dr. Reddy’s Laboratories Ltd, Alvogen, Indivior PLC, Hikma Pharmaceuticals PLC, Mylan N.V, Rhodes Pharmaceuticals L.P, Amneal Pharmaceuticals LLC, Mallinckrodt, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd and Lannett Co Inc.
Reasons to buy this Suboxone Market Report
☑ It attempts an analysis of the competing scenario.
☑ The current and exceptional product revenue market.
☑ An in-depth data on the regional investigation and competitive landscape structure.
☑ It benefits in creating an awareness of the important key product segments.
☑ The marketing strategies, opportunities, and development factors are explained.
☑ Suboxone market size estimation and recent advancements in the industry are explained.
SPECIAL OFFER (Avail an Up-to 30% discount on this report ) :
https://www.coherentmarketinsights.com/insight/buy-now/5000
Table of Content
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Formulation
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- New Product Launches
- Regulatory Scenario
- PEST Analysis
- PORTER’s Analysis
- Key Developments
- Brand Analysis
- Strategic Agreement, Merger And Acquisitions
- Market Dynamics
- Global Suboxone Market- Impact of Coronavirus (Covid-19) Pandemic
- Economic Impact
- COVID-19 Epidemiology
- Impact on Supply and Demand
- Global Suboxone Market, By Type, 2017 – 2030, (US$ Million)
- Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 – 2030
- Segment Trends
- Branded
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Generics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Overview
- Global Suboxone Market, By Formulation, 2017 – 2030, (US$ Million)
- Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 – 2030
- Segment Trends
- Tablets
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Films
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Overview
- Global Suboxone Market, By Distribution Channel, 2017 – 2030, (US$ Million)
- Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 – 2030
- Segment Trends
- Hospital pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Overview
- Global Suboxone Market, By Region, 2017 – 2030, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2018–2030
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 – 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 – 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 – 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 – 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 – 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 – 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
- UK
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 – 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 – 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 – 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 – 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 – 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 – 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 – 2030, (US$ Million)
- North Africa
- Central Africa
- South Africa
- Introduction
- Competitive Landscape
- Indivior PLC.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Dr. Reddy’s Laboratories Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Amneal Pharmaceuticals LLC.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Mylan N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Mallinckrodt
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Lannett Co Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Rhodes Pharmaceuticals L.P.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Alvogen
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sun Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Alkem Labs
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Hikma Pharmaceuticals PLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Indivior PLC.
- Section
- Research Methodology
- About Us
About Coherent Market Insights
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837